2Du ZD,Zhang TH,Li T,et al.Epidemiologic pictures of Kawasaki disease in Beijing from 1995 through 1999[J].Pediat Infect Dis J,2002,21 (2):103-107.
3Newburger JW,Takahashi M,Gerber MA,et al.Diagnosis,treatment,and long-term management of Kawasaki disease:a statement for health professionals from the Committee on Rheumatic Fever,Endocarditis and Kawasaki Disease,Council on Cardiovascular Disease in the Young,American Heart Association[J].Pediatrics,2004,114 ;1708-1733.[2]Newburger JW,Takahashi M,Gerber MA,et al.Diagnosis,treatment,and long-term management of Kawasaki disease:a statement for health professionals from the Committee on Rheumatic Fever,Endocarditis and Kawasaki Disease,Council on Cardiovascular Disease in the Young,American Heart Association[J].Pediatrics,2004,114 ;1708-1733.
5Yanagawa H,Sonobe T.Changes in the diagnostic guidelines for Kawasaki disease.In:Yanagawa H,Nakamuru Y,Yashiro M,Kawasaki T,editors.Epidemiology of Kawasaki disease:a 30-year achievement[M].Tokyo:Shindan-To-Chiryosha,2004:24 -32.
6Han RK,Silverman ED,Newman A,et al.Management and outcome of recurrent fever after intial intrarenous gammaglobulin therapy in acute Kawasaki disease[J].Arch Pediatr Adolesc Med,2000,154 (7):694-699.
7Wright DA,Newburger JW,Baker A,et al.Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids[J].J Pediatr,1996,128:146-149.
8Burns JC,Capparelli EV,Brown JA,et al.Intravenous gammaglobulin treatment and retreatment in Kawasakidisease.US/Canadian Kawasaki Syndrome Study Group[J].Pediatr Infect Dis J,1998,17:1144-1148.
10Fukunishi M,Kikkawa M,Hamada K,et al.Prediction of non-responsiveness to intravenous high-dose γ-glubulin therapy in patients with Kawasaki disease at onset[J].J Pediatr,2000,137:172-176.
